Beyond Dawlish

South Korea Generic Drug Market Overview

Market Statistics

Base Year: 2024

Historical Years: 2019-2024

Forecast Years: 2025-2033

Market Size in 2024: USD 7.4 Billion

Market Forecast in 2033: USD 10.2 Billion

Market Growth Rate: 3.64%(2025-2033)

According to the latest report by IMARC Group, the South Korea generic drug market size reached USD 7.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 10.2 Billion by 2033, exhibiting a growth rate (CAGR) of 3.64% during 2025-2033.

Request PDF Sample for more detailed market insights: https://www.imarcgroup.com/south-korea-generic-drug-market/requestsample

South Korea Generic Drug Market Industry Trends and Drivers:

More South Koreans are looking for affordable care which has caused a strong shift in the country’s generic drug market. As patents on several popular drugs end, pharmaceutical firms are making more generic versions which are cheaper alternatives. Because of more cases of aging and chronic diseases like diabetes and hypertension, patients and providers are looking for less expensive ways to manage their health. More government policies are now promoting generic substitution at pharmacies and hospitals which is making generic drugs more easily available. On top of that, local pharmaceutical companies are raising the quality of their products to comply with tough rules, so both consumers and healthcare professionals trust them and establish South Korea as a leader in making generic drugs worldwide.

Using technology and new ideas is starting to become common in the generic drug field. In order to increase efficiency and maintain high quality, South Korean firms are using modern techniques in manufacturing such as ongoing production and automation. Cooperation between local businesses and major drug companies is growing which helps spread useful knowledge and reach more people. The use of biosimilars, as part of generics designed for biologic drugs, is also increasing for complex diseases such as cancer and autoimmune disorders. To meet this goal, firms have stepped up their research, wanting to produce better, reasonably priced choices. Some businesses are paying attention to sustainability and switching to eco-friendly methods of packaging and production, fitting in with larger environmental objectives and exciting environmentally-conscious consumers.

South Korea Generic Drug Market Industry Segmentation:

The market report offers a comprehensive analysis of the segments, highlighting those with the largest South Korea Generic Drug Market share. It includes forecasts for the period 2025-2033 and historical data from 2019-2024 for the following segments.

The report has segmented the market into the following categories:

Therapy Area Insights:

• Central Nervous System
• Cardiovascular
• Dermatology
• Genitourinary/Hormonal
• Respiratory
• Rheumatology
• Diabetes
• Oncology
• Others

Drug Delivery Insights:

• Oral
• Injectables
• Dermal/Topical
• Inhalers

Distribution Channel Insights:

• Retail Pharmacies
• Hospital Pharmacies

Regional Insights:

• Seoul Capital Area
• Yeongnam (Southeastern Region)
• Honam (Southwestern Region)
• Hoseo (Central Region)
• Others

Competitive Landscape:

The report offers an in-depth examination of the competitive landscape. It includes a thorough competitive analysis encompassing market structure, key player positioning, leading strategies for success, a competitive dashboard, and a company evaluation quadrant. Additionally, the report features detailed profiles of all major companies in the South Korea Generic Drug industry.

Key highlights of the Report:

• Market Performance (2019-2024)
• Market Outlook (2025-2033)
• COVID-19 Impact on the Market
• Porter’s Five Forces Analysis
• Strategic Recommendations
• Historical, Current and Future Market Trends
• Market Drivers and Success Factors
• SWOT Analysis
• Structure of the Market
• Value Chain Analysis
• Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:  

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D)  91 120 433 0800
United States:  1-631-791-1145